HITshow Daily: October 7, 2025 (Tuesday)

Today on HITshow: U.S. News & World Report unveils the 2025–2026 Best Children’s Hospitals rankings, spotlighting excellence and access in pediatric care. Plus: Valley Children’s proves AI delivers measurable ROI, Kaiser braces for a multi-state strike, Qualtrics buys Press Ganey in a $6.7B experience data deal, Talkspace adds Wisdo Health for peer connection, and this year’s Nobel Prize honors breakthroughs in immune regulation. HOST: IDA KLEIN 🩺 October 7, 2025 📍 Feature — Ida KleinU.S. News & World Report releases its 2025–2026 Best Children’s Hospitals Rankings, offering new insight into pediatric excellence across 11 specialties — and growing attention to behavioral health, access, and equity. Managing Editor Ben Harder joins HITshow to explain how the data-driven analysis helps families and clinicians make informed decisions about care. 📍 Providers — Teresa VaughnAt Valley Children’s Hospital, artificial intelligence is delivering measurable ROI — cutting wait times, improving sepsis detection, and optimizing staffing decisions through predictive analytics embedded in daily operations. 📍 Workforce & Culture — Peter BetterworthKaiser Permanente faces a potential multi-state strike involving more than 75,000 workers, as contract negotiations stall over staffing and pay. Analysts warn the standoff could signal wider workforce stress as health systems enter Q4. 📍 Finance & M&A — Logan StokesQualtrics acquires Press Ganey in a $6.7 billion deal that fuses experience management with clinical quality data. The move aims to connect satisfaction, safety, and outcomes — turning patient experience into a measurable driver of performance. 📍 Telehealth & Remote Care — Jade RomeroTalkspace acquires Wisdo Health, adding AI-guided peer communities to its mental health platform. The deal expands Talkspace’s model beyond therapy sessions — blending community, coaching, and behavioral engagement in a unified ecosystem. 📍 Science & Discovery — Jalen CrossThe 2025 Nobel Prize in Medicine goes to Dr. Jeffrey Bluestone (UCSF) and Dr. Shimon Sakaguchi (Osaka University) for identifying regulatory T cells, unlocking new therapies for autoimmune diseases and advancing precision immunology. 🎧 Subscribe here or wherever you listen to podcasts, and if you like our show, please follow us on LinkedIn at https://www.linkedin.com/company/hit.show. HITshow is made possible by HLTH 2025.